The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
4-Hydroxylation of estrogens as marker of human mammary tumors.
Open accessAbstract
Estrogen is a known risk factor in human breast cancer. In rodent models, estradiol has been shown to induce tumors in those tissues in which this hormone is predominantly converted to the catechol metabolite 4-hydroxyestradiol by a specific 4-hydroxylase enzyme, whereas tumors fail to develop in organs in which 2-hydroxylation predominates. We have now found that microsomes prepared from human mammary adenocarcinoma and fibroadenoma predominantly catalyze the metabolic 4-hydroxylation of estradiol (ratios of 4-hydroxyestradiol/2-hydroxyestradiol formation in adenocarcinoma and fibroadenoma, 3.8 and 3.7, respectively). In contrast, microsomes from normal tissue obtained either from breast cancer patients or from reduction mammoplasty operations expressed comparable estradiol 2- and 4-hydroxylase activities (corresponding ratios, 1.3 and 0.7, respectively). An elevated ratio of 4-/2-hydroxyestradiol formation in neoplastic mammary tissue may therefore provide a useful marker of benign or malignant breast tumors and may indicate a mechanistic role of 4-hydroxyestradiol in tumor development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Endogenous Hormones and Breast Cancer Risk
Bernstein, L., & Ross, R. K. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036116 · Cited by 691
A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., & Pasternack, B. S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.190 · Cited by 620
Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y., Jabs, E. W., Li, X., Yin, H., Cody, C. W., & Greenlee, W. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36803-5 · Cited by 508
P450 enzymes of estrogen metabolism
Martucci, C. P., & Fishman, J. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90057-k · Cited by 392
Carcinogenicity of catechol estrogens in Syrian hamsters
Liehr, J. G., Wan-Fen, F., Sirbasku, D. A., & Ari-Ulubelen, A. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90080-4 · Cited by 356
Self-citationToward the Primary Prevention of Cancer
Henderson, B. E., Ross, R. K., & Pike, M. C. (1991) · Science · doi:10.1126/science.1957166 · Cited by 355
Newbold, R. R., Bullock, B. C., & McLachlan, J. A. (1990) · PubMed · Cited by 314
Free radical generation by redox cycling of estrogens
Liehr, J. G., & Roy, D. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90108-u · Cited by 295
Self-citationEstrogen Metabolism and Excretion in Oriental and Caucasian Women
Adlercreutz, H., Gorbach, S. L., Goldin, B. R., Woods, M. N., Dwyer, J. T., & Hamalainen, E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.14.1076 · Cited by 251
Cited by
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 971
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616
Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations
Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., & Roy, D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024247 · Cited by 595
Self-citationIs Estradiol a Genotoxic Mutagenic Carcinogen?1
Liehr, J. G. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0386 · Cited by 484
Self-citationBartsch, H., Nair, J., & Owen, R. W. (1999) · Carcinogenesis · doi:10.1093/carcin/20.12.2209 · Cited by 480
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention
Androutsopoulos, V. P., Tsatsakis, A. M., & Spandidos, D. A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-187 · Cited by 476
Cavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.03.001 · Cited by 409
Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation
Yager, J. D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024245 · Cited by 398
Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance
Clarke, R., Leonessa, F., Welch, J. N., & Skaar, T. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01479-0 · Cited by 397
Estrogen metabolism and breast cancer
Samavat, H., & Kurzer, M. S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.04.018 · Cited by 380
Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2
Köhle, C., & Bock, K. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.009 · Cited by 342
Molecular Details of cAMP Generation in Mammalian Cells: A Tale of Two Systems
Kamenetsky, M., Middelhaufe, S., Bank, E. M., Levin, L. R., Buck, J., & Steegborn, C. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.07.045 · Cited by 339
Regulation, Function, and Tissue-Specific Expression of Cytochrome P450 CYP1B1
Murray, G. I., Melvin, W. T., Greenlee, W. F., & Burke, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.297 · Cited by 336
Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
Spink, D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.291 · Cited by 308
Catalytic properties of polymorphic human cytochrome P450 1B1 variants
Shimada, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1607 · Cited by 270
Estrogen-induced cardiorenal protection: potential cellular, biochemical and molecular mechanisms.
Dubey, R. K., & Jackson, E. K. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f365 · Cited by 263
“hamsters estradiol induces tumor formation and causes cancer, and these effects are thought to be mediated via the estradiol metabolite 4-hydroxyestradiol (148).”
BackgroundSerum Hormones and the Alcohol-Breast Cancer Association in Postmenopausal Women
Dorgan, J. F., Baer, D. J., Albert, P. S., Judd, J. T., Brown, E. D., Corle, D. K., Campbell, W. S., Hartman, T. J., Tejpar, A. A., Clevidence, B. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.710 · Cited by 263
Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
Jefcoate, C. R., Liehr, J. G., Santen, R. J., Sutter, T. R., Yager, J. D., Yue, W., Santner, S. J., Tekmal, R., Demers, L., Pauley, R., et al. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024248 · Cited by 260
Self-citationBadawi, A. F., Cavalieri, E. L., & Rogan, E. G. (2001) · Metabolism · doi:10.1053/meta.2001.25592 · Cited by 184
(2000) · PubMed · Cited by 131
(2000) · PubMed · Cited by 99
Dioxin and endometrial progesterone resistance
Bruner-Tran, K., Ding, T., & Osteen, K. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242995 · Cited by 66
Metadata
- Authors
- Liehr, J. G., & Ricci, M. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-04-16
- Volume
- 93
- Issue
- 8
- Pages
- 3294-3296
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2002597568
- Cited by
- 414
- References
- 27
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.